Remix Therapeutics
Our Science
Platform
Pipeline
REM-422
About Us
Our Story
Our People
Our Investors
Our Partners
Join Us
News
News
Press Releases
Publications
Clinical Trials
Our Science
Platform
Pipeline
REM-422
About Us
Our Story
Our People
Our Investors
Our Partners
Join Us
News
News
Press Releases
Publications
Clinical Trials
Contact
Oct | 10 | 2024
Publication
A sequential binding mechanism for 5′ splice site recognition and modulation for the human U1 snRNP
Nature Communications
Read Article
Back to News
Media Contact
media@remixtx.com
Investor Contact
WILL O’CONNOR
Precision AQ
Will.OConnor@precisionaq.com